Understanding how people living with multiple sclerosis grapple with symptoms and respond to medication is becoming a top priority for neurologists and drug companies, said health professionals in town for the MSBoston2014 convention, which opened Wednesday.
“We’ve focused a lot on the neurologists’ impressions of how people are doing,” Dr. Jeffrey A. Cohen, director of the Mellen Center for Multiple Sclerosis Treatment and Research at the Cleveland Clinic, said during a press briefing. “Now we realize it’s important to get the patients’ input.”
MS patients and advocates are a major presence at MSBoston2014 — the largest MS scientific meeting ever, with more than 8,500 people registered — and at various events surrounding the convention. MSBoston2014, which runs through Saturday at the Hynes Convention Center, is sponsored jointly by the Americas and European Committees for Treatment and Research in Multiple Sclerosis.